Anti-HER2 functionalized graphene oxide as survivin-siRNA delivery carrier inhibits breast carcinoma growth in vitro and in vivo
Authors:
Open Access
- 1 September 2018
- journal article
- research article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 12, 2841-2855
Abstract
Background: The success of gene therapy is mostly dependent on the development of gene carrier. Graphene oxide (GO) possesses excellent aqueous solubility and biocompatibility, which is important for its biochemical and medical applications. Our previous work proved that GO can deliver siRNA into cells efficiently and downregulate the expression of desired protein. Methods: In this study, a novel delivery carrier, GO-R8/anti-HER2 (GRH), was developed by conjugating octaarginine (R8) and anti-HER2 antibody with GO as a tumor active-targeting vector for survivin-siRNA delivery. Results: GRH/survivin-siRNA formed nanoglobes of 195±10 nm in diameter. Real-time polymerase chain reaction analysis revealed that survivin messenger RNA expression showed a 42.4%±2.69% knockdown. The expression of survivin protein was downregulated to 50.86%±2.94% in enzyme-linked immunosorbent assay. In MTT tests, GRH exhibited no testable cytotoxicity. In vivo, GRH/survivin-siRNA showed gene silencing and inhibition of tumor growth. Conclusion: The in vitro and in vivo results consistently demonstrated that GRH/survivin-siRNA has potential to be an efficient gene silencing carrier for siRNA delivery in cancer therapy.Keywords
This publication has 41 references indexed in Scilit:
- Carboxylated graphene oxide functionalized with β-cyclodextrin—Engineering of a novel nanohybrid drug carrierInternational Journal of Biological Macromolecules, 2016
- PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapyBiomaterials, 2014
- Polyethylene Glycol and Polyethylenimine Dual‐Functionalized Nano‐Graphene Oxide for Photothermally Enhanced Gene DeliverySmall, 2013
- Polycation-based nanoparticle delivery of RNAi therapeutics: Adverse effects and solutionsAdvanced Drug Delivery Reviews, 2012
- Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNABiomaterials, 2012
- Engineered Redox‐Responsive PEG Detachment Mechanism in PEGylated Nano‐Graphene Oxide for Intracellular Drug DeliverySmall, 2012
- The use of polyethylenimine-grafted graphene nanoribbon for cellular delivery of locked nucleic acid modified molecular beacon for recognition of microRNABiomaterials, 2011
- Chitosan‐Functionalized Graphene Oxide as a Nanocarrier for Drug and Gene DeliverySmall, 2011
- Novel hybrid silica xerogels for stabilization and controlled release of drugInternational Journal of Pharmaceutics, 2007
- RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculatureDrug Resistance Updates, 2005